Fig. 5: MTHFD2 inhibitors exacerbate uracil misincorporation into DNA. | Nature Cancer

Fig. 5: MTHFD2 inhibitors exacerbate uracil misincorporation into DNA.

From: Pharmacological targeting of MTHFD2 suppresses acute myeloid leukemia by inducing thymidine depletion and replication stress

Fig. 5: MTHFD2 inhibitors exacerbate uracil misincorporation into DNA.

a, Proposed mechanism for the antitumor effect of MTHFD2 inhibitors via thymine-less-induced RS. MTHFD2 supports de novo thymidylate synthesis by providing CH2-THF. On MTHFD2 inhibition, accumulation of dUMP promotes uracil misincorporation, causing DNA damage. Failing to repair these lesions, cells undergo RF collapse and cell death. A combination of MTHFD2 and dUTPase inhibitors further increases uracil misincorporation and apoptosis. Thymidine supplementation bypasses this, rescuing DNA replication and cell viability. CDA, cytidine deaminase; DSBs, double-strand breaks; dUTPasei, dUTPase inhibitor; TK, thymidine kinase. b, Comet assay in THP-1 cells. Scale bar, 2 μm. Dot plots represent comet tail moment per cell and bars display the mean (n = 200 cells per condition). ****P < 0.0001; one-way Kruskal–Wallis test with Dunn’s multiple comparison correction (F = 904.2, d.f. = 9). c, Genomic uracil incorporation on TH7299 in THP-1 cells (10 μM, 48 h). Bars represent dU lesions as fold-change over DMSO displayed as means (n = 2). One of two independent experiments is shown. **P < 0.01, ***P < 0.001; one-way ANOVA (F = 156.4, d.f. = 2). d, Genomic uracil incorporation in HL-60 cells (TH9619 100 nM ± dUTPase inhibitor 10 µM, MTX 100 nM, 5-FU 10 μM ± thymidine 10 μM, 48 h). Bars represent dU lesions per million deoxynucleotides (MdN). Data are displayed as pooled means ± s.d. from two independent experiments performed in triplicate. **P = 0.0063, ****P < 0.0001; two-way ANOVA with Holm–Šídák correction for multiple comparisons (Ftreatment = 48.64, Fthymidine = 87.47, d.f.treatment = 5, d.f.thymidine = 1). e, Comet assay in THP-1 cells on TH7299 ± dUTPase inhibitor (10 μM, 24 h). Dot plots represent tail moment per cell and bars display the mean (n = 200 cells per condition). ***P < 0.001, ****P < 0.0001; one-way Kruskal–Wallis test with Dunn’s multiple comparison correction (F = 361.4, d.f. = 9). f, THP-1 cell viability on TH9028–dUTPase inhibitor combination ± thymidine 10 μM at 72 h. One of three independent experiments is shown. Data are displayed as means (n = 2). g, Apoptosis analysis in THP-1 cells. Approximately 15,000 events per condition were analyzed. Bars represent annexin-V-positive populations as means (n = 2). *P24h = 0.0151, *P72h = 0.0213, **P = 0.0029, ***P = 0.0002; one-way ANOVA (F = 43.89, d.f. = 5). One of two independent experiments is shown.

Source data

Back to article page